Cite

HARVARD Citation

    Andritsos, L. et al. (2019). Clinical and cost outcomes of pre-emptive plerixafor administration in patients with multiple myeloma undergoing stem cell mobilization. Leukemia research. p. . [Online]. 
  
Back to record